Valery E. P. P. Lemmens

Pharmacogenetics of oxaliplatin as adjuvant treatment in colon carcinoma: are single nucleotide polymorphisms in GSTP1, ERCC1, and ERCC2 good predictive markers?

A. V. D. van den Brule, A. Fariña Sarasqueta, G. van Lijnschoten, 2011, Molecular diagnosis & therapy.

Pharmacogenetics of Oxaliplatin as Adjuvant Treatment in Colon Carcinoma Are Single Nucleotide Polymorphisms in GSTP 1 , ERCC 1 , and ERCC 2 Good Predictive Markers ?

Valery E. P. P. Lemmens, H. Rutten, A. F. Sarasqueta, 2012 .